retatrutide phase 2 type 2 diabetes trial

retatrutide phase 2 type 2 diabetes trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Lilly's triple agonist, retatrutide, successful

Name: retatrutide phase 2 type 2 diabetes trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Lilly's triple agonist, retatrutide, successful
Brand: coasta-de-azur.fr
SKU: 48817387814
Price: 29.44 USD
Availability: InStock
Rating: 4.680400000000001 (23 reviews)

SKU: 48817387814

4.7

USD29.44 USD79.44

Pay in 4 interest-free payments of $7.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Romero M, Toral M, Gomez-Guzman M, et al

In poorly managed T2DM treated with basal insulin, tirzepatide can improve glucose control without hypoglycemia risk, alone or in combination with other oral hypoglycemic medications [79]